Agios Pharmaceuticals (United States)
Agios Pharmaceuticals Inc. is a publicly trading American pharmaceutical company pioneering therapies for genetically defined diseases, with a near-term focus on developing therapies for hemolytic anemias. The company was founded in 2008 by Lewis Cantley, Tak Mak and Craig Thompson. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Agios Pharmaceuticals (United States), United States, covering academic research published from 2009 to 2024. Read More.
Open Access Percentage
63%
Total
Publications
583
Total Open
Publications
366
Total
Citations
43K
Open Access
Percentage
63%
Total
Publications
583
Total Open
Publications
366
Total
Citations
43K
Breakdown
Publisher Open
25%
Both
27%
Other Platform Open
11%
Closed
37%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 29%
89
Hybrid 24%
74
No Guarantees 47%
141
Other Platform Open
Domain 91%
198
Institution 17%
36
Other Internet 11%
23
Preprint 8%
18
Public 5%
10
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 196 |
Europe PMC | Domain | 84 |
DOI | Other Internet | 18 |
Figshare | Public | 17 |
bioRxiv | Preprint | 16 |
California Digital Library - eScholarship | Other Internet | 11 |
Utrecht University - Utrecht University Repository | Institution | 7 |
University of Oxford - Oxford University Research Archive (ORA) | Institution | 4 |
University of Michigan - Deep Blue | Institution | 4 |
University of California - eScholarship University of California | Institution | 4 |